MedPath

Effect of cyclic versus continuous enteral nutrition on circadian rhythms in critical illness: the CIRCLES study

Recruiting
Conditions
alle aandoeningen met een Intensive Care indicatie
Enteral Nutrition
Intensive Care
Registration Number
NL-OMON51811
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Age 18 years or older
Receiving of or intention to start enteral nutrition via nasogastric or
nasoduodenal tube
Arterial line
Expected duration of ICU admission > 48 hours

Exclusion Criteria

• Receiving parenteral nutrition
• Oral intake
• Prior night-time (20.00h - 8.00h) enteral or parenteral nutrition within the
same hospitalization before study inclusion
• Readmission to ICU with prior study inclusion
• Chronic enteral tube feeding prior to current admission
• Presence of one or more contraindications of enteral feeding and/or at
significant risk for gastrointestinal tolerance according to standard protocol
(including but not limited to gastrointestinal haemorrhage, intestinal ischemia
or necrosis, impaired digestive tract integrity due to obstruction or
perforation, gastrectomy, enterectomy, history of gastroparesis or oesophageal
dysmotility or expected surgery within 24 hours)
• Patients with glycaemic emergency (including but not limited to
hyperglycaemic hyperosmolar nonketotic coma, diabetic ketoacidosis, severe
hypoglycaemia resulting in ICU admission) or patients controlling their glucose
levels and insulin dosing via continuous glucose monitoring
• Treatment with extracorporeal membrane oxygenation
• Severe neurological damage (significant neurological abnormalities such as
bleeding, ischemia, neurotrauma or severe encephalopathy with Glasgow Coma
Scale <= 8)
• Suspected or confirmed pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Main study parameters are the 24-h rhythm in core body temperature at day 3 of<br /><br>the study period, assessed by amplitude and acrophase of cosinor fits</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary study parameters are the difference between daytime and night-time<br /><br>melatonin levels at day 3 of the study period, 24-h rhythms in systolic blood<br /><br>pressure, heart rate and heart rate variability, 24-hour rhythms in circulating<br /><br>metabolites, peripheral clock gene expression, depth of sleep, mean daily rate<br /><br>of hyperglycaemia/hypoglycaemia, mean daily glucose variability, mean daily<br /><br>insulin administration, compliance to study protocol, mean daily caloric<br /><br>intake, daily rates of gastric residual volume > 200 mL, 28-day mortality, days<br /><br>on mechanical ventilation and ICU length of stay</p><br>
© Copyright 2025. All Rights Reserved by MedPath